GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kaya Holdings Inc (OTCPK:KAYS) » Definitions » ROE % Adjusted to Book Value

KAYS (Kaya Holdings) ROE % Adjusted to Book Value : 0.00% (As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is Kaya Holdings ROE % Adjusted to Book Value?

Kaya Holdings's ROE % for the quarter that ended in Sep. 2024 was 0.00%. Kaya Holdings's PB Ratio for the quarter that ended in Sep. 2024 was N/A. Kaya Holdings's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was N/A.


Kaya Holdings ROE % Adjusted to Book Value Historical Data

The historical data trend for Kaya Holdings's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kaya Holdings ROE % Adjusted to Book Value Chart

Kaya Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only Negative Equity - Negative Equity - Negative Equity

Kaya Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Negative Equity Negative Equity - Negative Equity -

Competitive Comparison of Kaya Holdings's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Kaya Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kaya Holdings's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kaya Holdings's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Kaya Holdings's ROE % Adjusted to Book Value falls into.



Kaya Holdings ROE % Adjusted to Book Value Calculation

Kaya Holdings's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=Negative Equity / N/A
=Negative Equity

Kaya Holdings's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kaya Holdings ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Kaya Holdings's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Kaya Holdings Business Description

Traded in Other Exchanges
N/A
Address
915 Middle River Drive, Suite 316, Fort Lauderdale, FL, USA, 33304
Kaya Holdings Inc is a holding company. It is focusing on wellness and mental health through operations in psychedelic treatment clinics, medical and recreational cannabis, and CBD products. The company own and operate a medical cannabis dispensary in the United States. Its has produced, distributed, and/or sold a full range of premium cannabis products including flower, oils, vape cartridges and cannabis infused confections, baked goods and beverages through a fully integrated group of subsidiaries and companies supporting highly distinctive brands.

Kaya Holdings Headlines

From GuruFocus